Number one, they probably want to work with NGIO d
Post# of 36537
(Total Views: 252)
Posted On: 01/06/2020 5:38:21 PM
Number one, they probably want to work with NGIO directly, or at least see the spin off complete. Number two, there is plenty of time. Probably want some safety data first, although I believe it is virtually a given the combo will be well tolerated.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼